MK-2060

Merck, seeking XI factor in race with Bayer, gets FDA fast-track tag for anticoagulant
Fierce Biotech
Tue, 08/23/22 - 10:32 am
Merck
Bayer
FDA
MK-2060
end-stage renal disease
ESRD
bloodthinners